The largest database of trusted experimental protocols

Tra 1 81

Manufactured by Santa Cruz Biotechnology
Sourced in United States

The TRA-1-81 is a monoclonal antibody produced by Santa Cruz Biotechnology. It is designed for the detection of the TRA-1-81 antigen, which is expressed on human embryonic stem cells and other pluripotent stem cells. The TRA-1-81 antibody can be used in various applications, such as flow cytometry, immunohistochemistry, and Western blotting, to identify and characterize these cell types.

Automatically generated - may contain errors

14 protocols using tra 1 81

1

Pluripotency Validation of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To confirm pluripotency, the newly generated colonies were immunostained with OCT3/4 (1:50), NANOG (1:50), SSEA4 (1:50), and TRA-1-81 (1:200) (Santa Cruz Biotechnologies, Dallas, Texas, USA) at the given concentrations. The colonies were fixed in 3% paraformaldehyde for 30 minutes, washed with phosphate-buffered saline (PBS) and permeabilized with PBS and 0.5% Triton. After blocking with 5% bovine serum albumin, the colonies were incubated with primary antibodies at appropriate concentrations overnight, followed by appropriate secondary antibody treatment. For multilineage cell staining, the cells were fixed with 3% paraformaldehyde and permeabilized with 0.5% Triton. After blocking with bovine serum albumin, the cells were incubated overnight with β-tubulin III (ectoderm marker, 1:50), nestin (endoderm marker, 1:50) and alpha smooth muscle actin (αSMA; mesoderm marker, 1:50) (Santa Cruz Biotechnologies), followed by appropriate secondary antibody treatment. The results were evaluated using a Leica Fluroscence DMI 4000-B (Leica Microsystems Heerbrugg, St Gallen, Switzerland).
+ Open protocol
+ Expand
2

Pluripotency Marker Analysis of hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reprogrammed hiPSCs (CMC-Fb-003) colonies were dissociated using Tryple Express (Life Technologies) and washed with PBS containing 10% FBS. Cell suspension was then stained with stage-specific embryonic antigens SSEA-4 (813-70, 1:100; Santa Cruz Biotechnology) or TRA-1-81 (TRA-1-81, 1:100; Santa Cruz Biotechnology) surface antibodies for 30 min. Intracellular staining for NANOG (1E6C4, 1:100; Santa Cruz Biotechnology) was performed by sequential incubations with fixation and permeabilization solutions (A and B Fix & Perm Solutions, Invitrogen, BD BioScience). These cells were incubated with FITC-conjugated secondary antibody (BD BioScience). Appropriate isotype controls were used for gating purposes (IgG3 isotype control to FITC (SSEA-4), IgM isotype control to FITC (TRA-1-81), IgG1 isotype control to FITC (NANOG)). Cells were analyzed using a FACS Canto II flow cytometer (BD Biosciences). Data were analyzed using a FlowJo software (TreeStar Inc., OR, USA).
+ Open protocol
+ Expand
3

Immunophenotyping of Stem Cells and Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
C3A-iCSCs, D6 and C10 cells were cultured on matrigel for 3 hours before formalin fixation. Permeabilization was performed with 10% Triton® X-100 and blocking with 10% bovine serum albumin (SIGMA-ALDRICH, St. Louis). Primary antibodies against the following molecules were used: NANOG (Abcam, England), OCT4 (Santa Cruz Biotechnology, Dallas), SOX2, SSEA4 (Chemicon, Billerica), TRA-1–81 (Santa Cruz Biotechnology, Dallas), AFP (Abcam, England), ALB (Abcam, England), Hnf4α (Cell Signaling, Danvers), and CD44 (Proteintech, Rocky Hill). Secondary antibodies were Alexa Fluor®488/594goat anti-rabbit/mouse IgGs (Origene, Rockville). Counter staining was performed with Hoechst 33342. Images were captured under a TCSSP5 Confocal Microscope (Leica, Buffalo Grove, USA). Merged images were obtained according to the recommended procedure using the Leica software.
+ Open protocol
+ Expand
4

Immunophenotyping of Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were fixed with 4% paraformaldehyde. Permeabilization was performed with 0.2% Triton X-100. Primary antibodies included NANOG, MITF, RPE65, ZO-1 (Abcam), OCT4, TRA-1-81 (Santa Cruz), SOX2, SSEA4, PAX6 (Chemicon). Secondary antibodies used were Alexa Fluor 488 or 594 goat anti-mouse/rabbit IgG antibody (ZSGB-BIO) diluted at 1:500. Cell nuclei were counterstained with Hoechst 33342. Labeled cells were imaged with a laser-scanning confocal microscope (Leica).
+ Open protocol
+ Expand
5

Characterization of Pluripotency Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were dissociated into single cells with Accutase (Invitrogen) and stained with primary antibodies for Tra-1–81 (Santa Cruz) and SSEA4 (Santa Cruz) for 1h on ice. Secondary antibody staining was performed for 30 min with R-PE-goat anti-mouse IgG and Alexa Fluor 488-donkey anti-mouse IgG&M. Data were collected with BD Accuri C6 flow cytometry (BD biosciences).
+ Open protocol
+ Expand
6

Generation of iPSCs from Human Foreskin Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human foreskin fibroblasts (line CRL-2429; ATCC, Rockville, MD, USA) were used to generate iPSC as previously described [16 (link)]. Cells were maintained in KnockOut™ DMEM supplemented with 20% KnockOut™ Serum Replacement, 2 mmol/l L-Glutamine, 40 µg/ml gentamycin, 100 µmol/l β-mercaptoethanol (Gibco, NY, USA) and 10 ng/ml of human fibroblast growth factor-basic (bFGF; PeproTech, UK). Medium was changed every day to maintain the cells undifferentiated. iPSC colonies were mechanically passaged every 4–5 days as described [16 (link)]. For characterization the iPSC colonies were immunostained with Oct ¾ (1:50), NANOG (1:50), Sox-2 (1:50), TRA-1-81 (1:50), TRA-1-60 (1:50) (Santacruz Biotechnologies, USA).
+ Open protocol
+ Expand
7

Pluripotency Marker Profiling and Karyotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pluripotency marker expression and normal karyotype was confirmed as described previously [31 (link)]. Briefly, the cells were fixed with 4% paraformaldehyde (PFA), washed with PBS, permeabilized with 0.1% Triton-X 100/PBS and blocked with 2% BSA/PBS. The cells were then incubated with primary antibodies: NANOG (4903S, Cell Signaling, Danver, MA,USA, 1:100), SOX2 (Y17, sc- 17320, Santa Cruz, Dallas, TX, USA, 1:100), OCT4 (C10, sc-5279, Santa Cruz, 1:100), SSEA3 (631, sc-21703, Santa Cruz, 1:100), SSEA4 (MC813, sc-59368, Santa Cruz, 1:100), TRA-1-60 (sc-21705, Santa Cruz), TRA-1-81 (sc-21706, Santa Cruz), followed by incubation with Alexa Fluor 594- or Alexa Fluor 488- conjugated secondary antibody (Thermo Fisher Scientific), and mounted with Vectashield with DAPI (Vector Laboratory, Burlingame, CA, USA). Alkaline phosphatase activity was detected by Vector Blue Alkaline Phosphatase Substrate Kit (Vector Laboratory) according to the manufacturer’s protocol. For karyotype analysis, the cells were arrested in metaphase with colcemide (KaryoMAX, Sigma-Aldrich, St. Louis, MO, USA), dissociated with trypsin/EDTA, treated with a hypotonic solution, and fixed with Carnoy’s fixative solution. Chromosomal G-bands were stained with Leishman’s staining solution (L6254, Sigma Aldrich).
+ Open protocol
+ Expand
8

Pluripotency Confirmation of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To confirm pluripotency, iPSC colonies were fixed (3% paraformaldehyde × 30 min), washed with phosphate-buffered saline (PBS) and permeabilized with 0.5% Triton. After blocking with 5% BSA, the colonies were incubated overnight with primary antibodies (OCT3/4, 1:50; NANOG, 1:50; TRA-1-60, 1:200; and TRA-1-81,1:200; all from Santa Cruz, Dallas, TX) followed by secondary antibody (anti-mouse Cy3, anti-rabbit FITC, 1:1,000). Isotype control antibodies were: anti-mouse IgG2b for OCT3/4, anti-goat IgG for Sox2 and Nanog, and anti-mouse IgM for TRA-1-60 and TRA-1-81 (all Abcam, Cambridge, UK). Images were taken using a confocal laser scanning microscope (LSM 710, Carl Zeiss, Germany).
For immunocytochemistry, 4% paraformaldehyde-fixed iPSCs were incubated with 3% donkey serum in 0.3% Triton X-100 in PBS (blocking) and exposed to rat anti-human αKlotho monoclonal antibody (1:1000, KM2076, overnight at 4°C, Trans Genic, Fukuoka, Japan), followed by incubation with secondary donkey anti-rat antibody conjugated to Alexa Fluor 555 (A31570, Invitrogen, Carlsbad, CA) at room temperature × 60min. Filamentous actin was labeled with rhodamine phalloidin (R415, Invitrogen), and nuclei with 4′,6-diamidino-2-phenylindole (DAPI, P36931, Thermo Fisher, Waltham, MA), and imaged with a laser scanning microscope (Zeiss LSM 880, Advanced Imaging Microscopy, Germany).
+ Open protocol
+ Expand
9

Immunocytochemical Characterization of SCA-3 iPSCs-derived Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
IPSCs-derived neurons from SCA-3 patients were fixated with 4% paraformaldehyde for 20 min. Cells were blocked in 5% normal goat serum and 2% fetal calf serum; subsequently, samples were probed with primary antibodies: TRA-1–81 (Santa Cruz; sc-21706), TRA-2–54 (made by group Peter Andrews lab, The University of Sheffield), OCT-4 (Santa Cruz; sc-5279), SOX-2 (Cell Signaling; #4900S) and βIII-tubulin (Abcam; ab7751). Alexa 488 and Cy3-conjugated secondary antibodies were used in combination with Hoechst nuclear staining (1:1000). Images were obtained using a Leica TCS SP8 confocal microscope (Leica Microsystems).
+ Open protocol
+ Expand
10

Pluripotent Stem Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used primary antibodies for Oct4, Nanog, Sox2, tropomyosin 1 (Cell Signaling Technology), β-actin, Tra1–60, Tra1–81, SSEA4, cardiac troponin T, and alpha sarcomeric actin (Santa Cruz Biotechnology, Inc.) to perform in vitro analysis. Secondary antibodies such as HRP-conjugated donkey anti–mouse, anti–rabbit, anti–goat (Santa Cruz Biotechnology, Inc.); TRITC-, FITC-, and Cy-5-conjugated donkey anti–mouse, anti–goat, and anti–rabbit (Jackson Immunoresearch Laboratories, Inc.) were used. DAPI (Life-Tech); Matrigel (BD Biosciences) NutriStem medium, alkaline phosphatase assay kit (Stemgent, Cambridge, MA); RPMI medium, Mytomycin C (Sigma-Aldrich, USA). StemRNA Reprogramming kit (Reprocell USA Inc).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!